GRAL logo

GRAIL INC

GRALNASDAQ
🏆 #1219 by market capUS Equity
$327.42▼ $22.20 (−6.78%)
Simulated price
🔔
Track GRAL
Get earnings, price moves & breaking news on Telegram
Track
24h▼ 6.8%
7d▲ 201.7%
14d▲ 336.5%
30d▲ 313.0%
ytd▲ 282.5%
1y▲ 454.2%
🏦Market Cap
$5.69B
Small Cap
📈Revenue Growth (YoY)
+17.2%
Healthy
📊Gross Margin
-10.8%
Thin
💵FCF Margin
-178.7%
Thin
⚖️P/S Ratio
34.4x
Expensive
Otter Score
48
Weak

Trading Snapshot

Day Range
$322.63 – $328.87
52-Week Range
$41.50 – $134.42
Volume
$4.03B
Avg Volume
$5.12B
Shares Outstanding
42.9M
Next Earnings
Oct 29, 2026

Fundamentals Snapshot

Annual Revenue
$147M
Last Q Revenue
$45M
P/E Ratio
-13.6
P/S Ratio
34.4x
EPS (TTM)
$-9.08
Dividend Yield
0.00%
Dilution (1yr)
+27.7%

Why Investors Own GRAL

  • ✓High-growth profile — revenue up +14.6% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 65% gross margin and 4% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

GRAL logo

GRAIL INC

GRAL
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$147M▲ +17.2% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
-42.5%▼ −31.6% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$534M▼ −75.6% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$299M▼ −48.7% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
40.7M▲ +27.7% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$152M▲ +$6M YoY
StockOtter · stockotter.space

About GRAIL INC

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Weak
48/100

Analyst Price Target

ⓘ
Average Target
$375.48
▲ +14.7% Upside
High Target$467.23
Low Target$308.69
Based on 37 analysts

Latest News & Updates

🚀
CNBC·2h ago

GRAIL INC tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
Reuters·5h ago

Analysts lift GRAL price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
MarketWatch·1d ago

GRAIL INC announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.